NuWave Investment Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-7,611
Closed -$274K 288
2020
Q4
$274K Sell
7,611
-330
-4% -$11.9K 0.36% 93
2020
Q3
$304K Buy
7,941
+7,523
+1,800% +$290K 0.47% 65
2020
Q2
$15K Buy
+418
New +$15.1K 0.02% 295
2020
Q1
Sell
-5
Closed 225
2019
Q4
$0 Sell
5
-716
-99% -$30K ﹤0.01% 424
2019
Q3
$27K Buy
721
+380
+111% +$16.1K 0.03% 308
2019
Q2
$15K Sell
341
-12,407
-97% -$477K 0.02% 323
2019
Q1
$490K Buy
12,748
+12,601
+8,572% +$481K 0.58% 59
2018
Q4
$5K Sell
147
-170
-54% -$6.17K 0.01% 295
2018
Q3
$12K Sell
317
-18,172
-98% -$635K 0.02% 238
2018
Q2
$605K Buy
18,489
+11,838
+178% +$357K 0.79% 45
2018
Q1
$183K Sell
6,651
-29,148
-81% -$792K 0.29% 113
2017
Q4
$887K Buy
+35,799
New +$987K 1.04% 19
2014
Q3
Sell
-27,757
Closed -$354K 290
2014
Q2
$354K Buy
+27,757
New +$361K 0.91% 28

Other funds holding BSX

NuWave Investment Management's BSX Position: Q1 2021 in Review

NuWave Investment Management sold out of Boston Scientific (BSX) in Q1 2021, closing a stake of 7,611 shares — an estimated $274K sold.

NuWave Investment Management first reported a position in BSX in Q2 2014 and held it in 13 quarters. The position peaked at $887K in Q4 2017. 832 funds tracked by Wall St. Rank hold BSX as of Q1 2021.

  • NuWave Investment Management reported no remaining Boston Scientific position as of Q1 2021 after selling out during the quarter.
  • NuWave Investment Management sold 7,611 Boston Scientific shares in Q1 2021, an estimated $274K.
  • NuWave Investment Management first reported a position in Boston Scientific in Q2 2014 and held it in 13 quarters.
  • NuWave Investment Management's Boston Scientific position peaked at $887K in Q4 2017.
  • 832 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2021.

Based on NuWave Investment Management's 13F filing for Q1 2021, filed 9 Apr 2021.